Clinical Trials


Gynecologic Cancer Trial Finder

The following treatment trials, arranged by primary disease site (ovary, endometrium and cervix) are currently available at SCCA and some participating community cancer centers. Non-treatment trials (imaging and supportive care) are listed below the treatment trails. Additional information for each study is available by contacting the listed research coordinator. Click on the headings below to view relevant trials for the condition listed.

Ovarian Cancer: Newly Diagnosed (1 trial)

Ovarian Cancer: Maintenance Therapy for Advanced Cancer in Complete Remission Following Treatment (1 trial)

  • Paclitaxel vs Polyglutamate Paclitaxel (GOG 212)
    A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12 Monthly Cycles of Single Agent Paclitaxel or Xyotax (CT-2103) (IND# 70177), Versus No Treatment Until Documented Relapse in Women With Advanced Ovarian or Primary Peritoneal or Fallopian Tube Cancer Who Achieve a Complete Clinical Response to Primary Platinum/Taxane Chemotherapy

Ovarian Cancer: Recurrent Platinum Sensitive (1 trial)

  • Carboplatin + Paclitaxel w/wo Bevacizumab After Surgery (GOG 213)
    A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel Alone or in Combination With Bevacizumab (NSC #704865, IND #7921) Followed by Bevacizumab and Secondary Cytoreduction Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer

Ovarian Cancer: Platinum Refractory (2 trials)

Ovarian Cancer: Recurrent Platinum Resistant (4 trial)

Carcinosarcoma (Ovarian or Uterine) (0 trials)

Trials pending. None currently open.

Endometrial Cancer: Early Stage (0 trials)

Trials pending. None currently open.

Endometrial Cancer: Advanced Stage (1 trial)

Endometrial Cancer: Recurrent (1 trial)

Cervical Cancer: Newly Diagnosed (1 trial)

Cervical Cancer: Recurrent (0 trials)

Trials pending. None currently open.

Imaging & Supportive Care (2 trials)

Clinical Trial Finder beta 2 updated 10/9/13.